IPO registrations (S-1, F-1) · Registrants
Diadexus, Inc.
- SEC CIK
- 1036968 · filings on EDGAR ↗
- Name on the registration
- VAXGEN INC
- Former names
- VAXGEN INC (1999–2010)
- Registration
- Form S-1, first filed 1999-05-07, last 2008-02-01; 2 initial registrations, 4 amendments
- Outcome
- Final prospectus filed 1999-06-30; declared effective 2008-02-04
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 349 OYSTER POINT BOULEVARD, South San Francisco, CA 94080
- EIN
- 94-3236309
- EDGAR entity type
- operating
- Insiders and CEO pay
- Diadexus, Inc. on the corporate pages
Offering terms
- Proposed price range
- $13.00–$15.00 per share (S-1/A filed 1999-06-25)
- Final price
- $13.00 per share, within the range (424B4 filed 1999-06-30, an initial public offering)
- Shares sold
- 3,100,000
- Gross proceeds
- $40,300,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol VXGN
- Lead underwriters
- Prudential Securities
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: diaDexus, Inc. Fuzzy (name and state)
- Form 5500 plan sponsor: DIADEXUS, INC. EXACT (EIN (EXACT))
- Federal award recipient: DIADEXUS, INC. Fuzzy (name and state)
- Lobbying client: DIADEXUS INC Fuzzy (name and state)
- SEC filer: diaDexus, Inc. EXACT (CIK (EXACT))
Filings 9
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 1999-05-07 | S-1 | S-1 (registration) | VAXGEN INC | 0000891020-99-000778 ↗ |
| 1999-06-11 | S-1/A | S-1/A (amendment) | VAXGEN INC | 0000891020-99-000999 ↗ |
| 1999-06-25 | S-1/A | S-1/A (amendment) | VAXGEN INC | 0000891020-99-001090 ↗ |
| 1999-06-30 | 424B4 | 424B4 (final prospectus) | VAXGEN INC | 0000891020-99-001116 ↗ |
| 2007-10-05 | S-1 | S-1 (registration) | VAXGEN INC | 0001169232-07-003829 ↗ |
| 2007-12-24 | S-1/A | S-1/A (amendment) | VAXGEN INC | 0000950134-07-026098 ↗ |
| 2008-02-01 | S-1/A | S-1/A (amendment) | VAXGEN INC | 0000950134-08-001485 ↗ |
| 2008-02-04 | EFFECT | EFFECT (declared effective) | VAXGEN INC | 9999999995-08-000405 ↗ |
| 2008-02-08 | EFFECT | EFFECT (declared effective) | VAXGEN INC | 9999999995-08-000473 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 1999-06-25 | S-1/A | registration statement | $13.00–$15.00 | $8.60 | 3,100,000 | $26,660,000 | Nasdaq VXGN | 1 | from the submission text; range, price line, shares headline, proceeds computed, cover names 1 | document ↗ |
| 1999-06-30 | 424B4 | final prospectus | $13.00 | 3,100,000 | $40,300,000 | Nasdaq VXGN | 1 | from the submission text; price sentence, shares headline, proceeds table, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| PFEFFER MATTHEW J | Officer | Chief Financial Officer; SENIOR VICE PRESIDENT AND CFO; Sr Vice President and CFO; SR VICE PRESIDENT AND CFO | 5 | 2006–2007 | |
| GRUBER & MCBAINE CAPITAL MANAGEMENT LLC | TenPercentOwner | 13 | 2007–2008 | ||
| Slater Eve Elizabeth | Director | Director | 1 | 2007 | |
| BERGER FRANKLIN M | Director | Director | 2 | 2007–2008 | |
| CAUDILL RANDALL L W | Director; DirectorOther | Chairman of the Board | 2 | 2007 | |
| GRECO MICHEL | Director | Director | 1 | 2007 | |
| GURWITH MARC J | Officer | Senior Vice President; SENIOR VICE PRESIDENT | 2 | 2007 | |
| IGNON R LANCE | Officer | Vice President | 1 | 2007 | |
| Levine Myron M | Director | Director | 1 | 2007 | |
| PANEK JAMES P | Director; Director,Officer; Officer | CHIEF EXECUTIVE OFFICER; President and CEO | 7 | 2007–2014 | |
| REILLY KEVIN LEO | Director | Director | 3 | 2007–2008 | |
| WHITEHEAD PIERS C | Officer | Vice President; VICE PRESIDENT | 3 | 2007 | |
| ANTHONY JACK M | Director | 2 | 2007 | ||
| RAFIELD LORI F PHD | Director; Director,Officer; DirectorOther | Chief Executive Officer; Interim CEO; Interim Executive Chair | 12 | 2008–2015 | |
| DeStefano Paul | Director | 3 | 2008–2009 | ||
| BA Value Investors, LLC | TenPercentOwner | 1 | 2009 | ||
| BRONSON STEVEN N | TenPercentOwner | 1 | 2009 | ||
| Boyer Mark Thomas | Other; TenPercentOwner | 2 | 2009 | ||
| ROI CAPITAL MANAGEMENT INC | Other; TenPercentOwner | 2 | 2009 | ||
| Soboleski Mitchell Joseph | Other; TenPercentOwner | 2 | 2009 | ||
| 14159 capital (GP), LLC | TenPercentOwner | 1 | 2010 | ||
| Baker Biotech Capital (GP), LLC | TenPercentOwner | 1 | 2010 | ||
| Baker Bros. Capital (GP), LLC | TenPercentOwner | 3 | 2010–2012 | ||
| Baker Brothers Life Sciences Capital (GP), LLC | TenPercentOwner | 1 | 2010 | ||
| BAKER FELIX | TenPercentOwner | 7 | 2010–2012 | ||
| BAKER JULIAN | TenPercentOwner | 7 | 2010–2012 | ||
| Alfano Bernard M. (Dino) | Officer | Executive Vice President & CCO; Executive VP and CCO | 3 | 2010–2011 | |
| BOCK LOUIS C | Director | 2 | 2010 | ||
| FOSTER DAVID J | Officer | Exe. VP, CFO and Secretary | 2 | 2010 | |
| Patrick Charles W | Director | 6 | 2010–2014 | ||
| Plewman Patrick | Director,Officer | President and CEO | 2 | 2010 | |
| WOLFERT ROBERT L | Officer | Executive VP and CSO | 2 | 2010 | |
| Drexler Karen | Director | 7 | 2010–2015 | ||
| Galligan Andrew H | Director | 6 | 2010–2014 | ||
| Zychlinsky Bulaevsky Emilia | Officer | Chief Technical Officer; Executive VP and CTO | 6 | 2011–2013 | |
| Burrill & CO (Indiana GP), LLC | TenPercentOwner | 3 | 2011–2013 | ||
| Burrill & CO (Life Sciences GP), LLC | TenPercentOwner | 3 | 2011–2013 | ||
| BURRILL & CO LLC | TenPercentOwner | 3 | 2011–2013 | ||
| Burrill Indiana Life Sciences Capital Fund, L.P. | TenPercentOwner | 3 | 2011–2013 | ||
| BURRILL LIFE SCIENCES CAPITAL FUND LP | TenPercentOwner | 3 | 2011–2013 | ||
| BURRILL STEVEN | TenPercentOwner | 3 | 2011–2013 | ||
| Ward Brian E. | Director; Director,Officer | President and CEO | 4 | 2011–2012 | |
| Richey Robert Michael | Officer | Chief Business Officer | 4 | 2011–2013 | |
| Viret Jean-Frederic | Officer | Chief Financial Officer | 4 | 2012–2014 | |
| OLUKOTUN ADEOYE Y | Director | 4 | 2013–2014 | ||
| Johnson Alexander L | Officer | President | 2 | 2014 | |
| Fang Kenneth C. | Officer | Chief Medical Officer | 2 | 2014 | |
| PATTERSON LEONE D | Officer | Chief Financial Officer | 2 | 2015 | |
| SULAT JAMES R | Director | 3 | 2015 | ||
| Hutt Pollard Elizabeth Ann | Director | 3 | 2015 | ||
| Curnutte John T | Director | 2 | 2015 | ||
| Sperzel John J III | Director | 2 | 2015 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | diaDexus, Inc. | CA | State business registries | name and state |
| Contractor | 23ANDME | CA | Nonprofit contractors (Form 990) | same street address and ZIP code, 349 OYSTER POINT BLVD 94080 (FUZZY: a shared address, not proof of a shared organization) |
| Federal award recipient | DIADEXUS, INC. | CA | Federal spending (USAspending) | name and state |
| Lobbying client | DIADEXUS INC | CA | Federal lobbying (LDA) | name and state |
| Patent assignee | diaDexus, Inc. | CA | Patents (USPTO) | name and state |
| SEC filer | Diadexus, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | diaDexus, Inc. | CA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | DIADEXUS, INC. | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, CA first:
- CONNETICS CORP CA
- SIBIA NEUROSCIENCES INC CA
- MEDIVATION, INC. CA
- IMMUSOL INC CA
- DYNAVAX TECHNOLOGIES CORP CA
- RIGEL PHARMACEUTICALS INC CA
- CymaBay Therapeutics, Inc. CA
- CRESCENDO PHARMACEUTICALS CORP CA
- SPIROS DEVELOPMENT CORP II INC CA
- BIOMARIN PHARMACEUTICAL INC CA
In other datasets, the same topic (Health) in CA:
- Nonprofit: 24 HOUR CANCER DANCE-A-THON (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health